309 results
Page 13 of 16
8-K
EX-99.1
aqj0xvcaktv a6rpawb
4 Nov 10
BioTime Announces Final Results of Warrant Exercises
12:00am
8-K
EX-99.1
j4ktcmiab lgi2
3 Nov 10
BioTime, Inc. Awarded $733,000 in Grants Under Qualifying Therapeutic Discovery Project Program
12:00am
8-K
EX-99.1
8p5x65w
26 Oct 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
nvd4anqu v4iu
22 Oct 10
Other Events
12:00am
8-K
EX-99.1
ttyrklbtz4
14 Oct 10
Regulation FD Disclosure
12:00am
8-K
EX-99.2
mq5n97zs
12 Oct 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
x9nyih
12 Oct 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
2ldtc foqrku
13 Sep 10
BioTime CEO Dr. Michael West to Present at Stem Cells USA & Regenerative Medicine Congress 2010
12:00am
8-K
EX-99.1
txo pcyjk
9 Sep 10
BioTime Announces Executive Management Changes
12:00am
8-K
EX-99.1
wc9hw3
26 Aug 10
Other Events
12:00am
8-K
EX-99.1
mhfdhckrxre h1
17 Aug 10
BioTime Announces Second Quarter 2010 Financial Results and Recent Corporate Developments
12:00am
8-K
EX-99.1
8w7k2u4s a391ir
21 Jul 10
BioTime Announces Addition of New Stem Cell Lines to Its Product Portfolio
12:00am
8-K
EX-99.1
6alfsjq itlesw
7 Jul 10
BioTime Announces Passing of Board Director Dr. Robert N. Butler
12:00am
8-K
EX-99.1
yjwg3n
14 Jun 10
BioTime Announces Results of Vote at Annual Shareholders Meeting
12:00am
8-K
EX-99.1
s39k2
11 Jun 10
BioTime Forms New Subsidiary, OrthoCyte Corporation, to Develop Treatments for Orthopedic Conditions Using Stem Cell Technology
12:00am
8-K
EX-99.1
mh6 azoxb
9 Jun 10
BioTime CEO Dr. Michael West to Present at the Inaugural Jefferies Global Life Sciences Conference
12:00am
8-K
EX-99.1
e9i nj1y5mvo4
27 May 10
BioTime Adds Five New Stem Cell Lines to Its Product Portfolio
12:00am
DEFA14A
mxfqkuca
14 May 10
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
8q8 8lpzleu2cfq
10 May 10
BioTime Announces Receipt of $8 Million from Early Exercise of Warrants
12:00am
8-K
EX-99.1
aujtsj
5 May 10
Biotime Announces First Quarter 2010
12:00am